title: Optimizing the use of the "state-of-the-art" performance criteria.
abstract: The organizers of the first EFLM Strategic Conference "Defining analytical performance goals" identified three models for defining analytical performance goals in laboratory medicine. Whereas the highest level of model 1 (outcome studies) is difficult to implement, the other levels are more or less based on subjective opinions of experts, with models 2 (based on biological variation) and 3 (defined by the state-of-the-art) being more objective. A working group of the German Society of Clinical Chemistry and Laboratory Medicine (DGKL) proposes a combination of models 2 and 3 to overcome some disadvantages inherent to both models. In the new model, the permissible imprecision is not defined as a constant proportion of biological variation but by a non-linear relationship between permissible analytical and biological variation. Furthermore, the permissible imprecision is referred to the target quantity value. The biological variation is derived from the reference interval, if appropriate, after logarithmic transformation of the reference limits.
authors: Rainer
authors: R
authors: Haeckel
authors: Werner
authors: W
authors: Wosniok
authors: Thomas
authors: T
authors: Streichert
mesh_terms: D019411:Clinical Laboratory Techniques / Q000592:standards*; D006801:Humans; D015588:Observer Variation; D017430:Prostate-Specific Antigen / Q000097:blood; D012016:Reference Values; D035501:Uncertainty
chemical_list: D017430:Prostate-Specific Antigen